Correspondence
SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: “Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?” by Manzo et al. Joint Bone Spine 2021;88:105150

https://doi.org/10.1016/j.jbspin.2021.105282Get rights and content

Keywords

SARS-CoV-2
COVID-19
Vaccine
Polymyalgia rheumatica
Giant cell arteritis

Cited by (0)

View Abstract
© 2021 Published by Elsevier Masson SAS on behalf of Société française de rhumatologie.